United States In Vitro Diagnostics Market Overview
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Growth Rate: 2.7% (2025-2033)
Market Size in 2024: USD 30.3 Billion
Market Forecast in 2033: USD 39.5 Billion
The United States in vitro diagnostics (IVD) market is experiencing steady growth, driven by the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the rising adoption of personalized medicine. The expanding geriatric population, which is more susceptible to conditions such as diabetes, cancer, and cardiovascular diseases, is further fueling demand for precise diagnostic solutions. Additionally, the heightened awareness regarding early disease detection and preventive healthcare is encouraging the use of IVD devices across various healthcare settings. Government initiatives promoting diagnostic advancements, coupled with the integration of artificial intelligence and machine learning in laboratory automation, are enhancing efficiency and accuracy in disease diagnosis. Moreover, the impact of the COVID-19 pandemic has significantly accelerated the adoption of rapid and point-of-care testing solutions, fostering continuous market expansion. According to the latest report by IMARC Group, the market size reached USD 30.3 billion in 2024 and is projected to reach USD 39.5 billion by 2033, exhibiting a CAGR of 2.7% during the forecast period.
United States In Vitro Diagnostics Market Trends and Drivers
In the United States, the IVD market is witnessing strong demand for molecular diagnostics, immunodiagnostics, and clinical chemistry testing, as these technologies are playing a crucial role in detecting infectious diseases and cancer. The increasing application of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies in genetic testing and oncology diagnostics is significantly improving early detection and treatment planning. Reagent and kit-based products remain the dominant segment, as they offer consistent and reliable test results while supporting high-throughput screening. The growing prevalence of lifestyle-related diseases, such as diabetes and cardiovascular disorders, is prompting the adoption of advanced IVD solutions in hospitals, clinical laboratories, and point-of-care testing centers. Additionally, the rising preference for home-based diagnostic solutions and self-monitoring devices is reshaping the market landscape, making healthcare more accessible and patient-centric.
The key drivers propelling the U.S. in vitro diagnostics market include the rapid expansion of personalized medicine, the continuous evolution of precision diagnostics, and increasing investment in research and development. Hospitals and clinical laboratories are prioritizing advanced diagnostic solutions to enhance patient outcomes, while biotechnology companies are focusing on developing innovative IVD technologies. The integration of digital health solutions and telemedicine platforms is further facilitating remote patient monitoring and diagnostic accuracy. Furthermore, the rising trend of at-home testing is creating new growth opportunities for manufacturers specializing in user-friendly and portable diagnostic devices. As regulatory frameworks continue to support technological innovation, the IVD market is expected to sustain its upward trajectory, reinforcing its pivotal role in modern healthcare diagnostics across the United States.
United States In Vitro Diagnostics Market Segmentation
The market report offers a comprehensive analysis of the segments, highlighting those with the largest market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments:
- Test Type:
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostics
- Hematology
- Others
- Product:
- Reagents and Kits
- Instruments
- Usability:
- Disposable IVD Devices
- Reusable IVD Devices
- Application:
- Infectious Disease
- Diabetes
- Cancer/Oncology
- Cardiology
- Autoimmune Disease
- Nephrology
- Others
- End User:
- Hospital Laboratories
- Clinical Laboratories
- Point-of-Care Testing Centres
- Academic Institutes
- Patients
- Others
- Regional Insights:
- Northeast
- Midwest
- South
- West
For an in-depth analysis, you can refer to a sample copy of the report: https://www.imarcgroup.com/united-states-in-vitro-diagnostics-market/requestsample
Competitive Landscape
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key highlights of the report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter's Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
